webinar register page

Webinar banner
Dialogue: Current Perspectives on Aducanumab
The goal of this public scientific discussion will be to provide a balanced collegial dialogue with an opportunity to discuss the science behind aducanumab, publicly available data surrounding the clinical trial results, the diagnostic biomarkers used to enroll in the trials, and the FDA label which dictates which populations this drug will benefit based on the evidence reviewed. We will also address the perspectives of individuals with Alzheimer’s and their carers. Lastly, we will discuss the future for the clinical community and the guidance needed for the immediate and longer term.

This will be a 4 hour event, with live panel discussions and interactive Q&A opportunities for attendees.


Welcome Remarks
Maria Carrillo, Philip Scheltens

Biology Behind the Approach & Target Engagement
Moderator: Dennis Selkoe
Panelists: David Holtzman, Bruce Lamb, Cynthia Lemere, Gil Rabinovici

Clinical Methods, Outcomes and Implications
Moderator: Ron Petersen
Panelists: Alireza Atri, Paul Aisen, Suzanne Craft, David Knopman, Stephen Salloway, Mary Sano

Patient/Caregiver Perspective
Moderators: Maria Carrillo, Monica Moreno
Panelists: Dan Gibbs, LuPita Gutierrez-Parker, Ricci Sanchez, Phyllis Roy

Path Forward
Moderator: Philip Scheltens
Panelists: Liana Apostolova, Alireza Atri, Jerry Barakos, Sharon Brangman, Pei-Jung Lin, Kathy Costello

Concluding Remarks
Philip Scheltens, Maria Carrillo

Jun 21, 2021 10:00 AM in Central Time (US and Canada)

* Required information